Forward blood typing
Q. I have a question about blood typing. I understand that in forward typing, we use anti-A and anti-B antibodies. (more…)
Q. I have a question about blood typing. I understand that in forward typing, we use anti-A and anti-B antibodies. (more…)
Q. I’m a medical student, and I wonder if you have some good tips about how to tell tell apart mononucleosis from AML on a blood smear? (more…)

Q. Can you explain a bit about the classification of B-cell lymphoma? (more…)
Good news for our readers in Italy: The Top 10 Anemias to Know for Boards is now available in Italian! A huge thank you to Francesco V. from Sicily for taking the time to translate the book for us.
Q. How come the PT and PTT are not increased in TTP and HUS? You have clots all over, so why don’t the coag tests go up like they do in DIC? (more…)
Q. Why do light chains appear in the urine in mu heavy chain disease but not in alpha or gamma heavy chain diseases?
Q. I understand that hemophilia is caused by factor VIII or IX deficiency and both factors work in the intrinsic pathway. (more…)
Q. Here’s a question from Twitter: Can you explain to me what the M protein in multiple myeloma is? (more…)
Here’s how you make a clot:
If you think back to the basics of the coagulation cascade, you might recall that there are two arms – an extrinsic arm and an intrinsic arm – which come together in the final common pathway, which ends up turning fibrinogen into fibrin. When somebody is bleeding, and you think it’s due to a coagulation problem (as opposed to a platelet problem), it’s helpful to know what part of the cascade is screwed up. That helps you figure out what’s wrong with the patient (is it hemophilia? or liver disease? or coumadin overdose?).
There are two main tests for evaluating the cascade: one for the extrinsic arm (the PT/INR) and one for the intrinsic arm (the PTT). There are other tests too – but those will have to be for another post.
1. The PT/INR
The prothrombin time (PT) is performed by adding thromboplastin to the patient’s plasma, and seeing how long it takes to make fibrin (as soon as you see the first strands of fibrin form, the test is over, and you measure the result in seconds.
Thromboplastin contains a tissue-factor-like substance, and therefore it just measures the extrinsic pathway. The annoying thing about thromboplastin is that its strength varies considerably from manufacturer to manufacturer. So the PT done at one hospital (using manufacturer A’s thromboplastin) will be significantly different than the PT done at another hospital (using manufacturer B’s thromboplastin). Dumb.
To deal with this annoying issue, someone figured out how to make some mathematical calculations that take into account each manufacturer’s thromboplastin strength. Now, you just do your PT assay, add on those mathematical calculations, and you wind up with something called the International Normalized Ratio (INR). This means that you can do the PT with anybody’s thromboplastin, and you’ll wind up with a result (the INR) that removes that variability. Super important.
2. The PTT
The PTT, or partial thromboplastin time, is performed by adding just some phospholipid to the patient’s plasma and waiting to see how long it takes to form fibrin. You have to add in a little “contact factor” like kaolin to activate XI to XIa – but other than that, that’s it!
It’s called the “partial thromboplastin” time because initially, it was found that by adding a part of thromboplastin to a test tube, you could activate fibrin formation. It turns out that the part of thromboplastin people were adding was just phospholipid, and that thromboplastin consists of both phospholipid and tissue factor. This test measures the intrinsic pathway, which is that arm of the cascade involving factors XI, IX, VIII and the final common pathway.
Q. I was wondering if you could help clarify two coagulation tests. (more…)
Recent Comments